Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient-derived xenografts
Hemasphere
.
2024 Jan 27;8(1):e28.
doi: 10.1002/hem3.28.
eCollection 2024 Jan.
Authors
Vilma Dembitz
1
2
,
Jozef Durko
1
,
Joana Campos
1
,
Sophie C James
1
,
Hannah Lawson
1
,
Kamil R Kranc
1
3
,
Paolo Gallipoli
1
Affiliations
1
Centre for Haemato-Oncology, Barts Cancer Institute Queen Mary University of London London UK.
2
Present address: Department of Physiology and Croatian Institute for Brain Research University of Zagreb School of Medicine Zagreb Croatia.
3
The Institute of Cancer Research London UK.
PMID:
38434525
PMCID:
PMC10878184
DOI:
10.1002/hem3.28
No abstract available
Grants and funding
26787/CRUK_/Cancer Research UK/United Kingdom
27964/CRUK_/Cancer Research UK/United Kingdom
MR/P010008/1/MRC_/Medical Research Council/United Kingdom
MR/P010008/2/MRC_/Medical Research Council/United Kingdom